TRAVOPROST

TRAVOPROST was reported 8671 times

TRAVOPROST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VERTEBRAL END PLATE INFLAMMATION 13 0.6500
1 MALIGNANT MEDIASTINAL NEOPLASM 42 0.3818
2 PERIORBITAL FAT ATROPHY 5 0.1163
3 ADRENAL CYST 12 0.1091
4 HEMISENSORY NEGLECT 3 0.0857
5 EYELASH THICKENING 10 0.0833
6 INTRAOCULAR PRESSURE FLUCTUATION 15 0.0761
7 EYELASH HYPERPIGMENTATION 3 0.0600
8 PRODUCT DROPPER ISSUE 45 0.0572
9 INTRAOCULAR PRESSURE DECREASED 28 0.0531
10 GROWTH OF EYELASHES 41 0.0518
11 GLAUCOMA DRAINAGE DEVICE PLACEMENT 3 0.0517
12 CONJUNCTIVAL CYST 3 0.0469
13 TRABECULECTOMY 4 0.0435
14 STAG HORN CALCULUS 4 0.0421
15 JOINT DEFORMITY 3 0.0400
16 CONJUNCTIVAL SCAR 6 0.0397
17 CORNEAL IRRITATION 3 0.0375
18 PRODUCT PRIMARY PACKAGING ISSUE 4 0.0357
19 MEIBOMIANITIS 3 0.0333
20 EYE OPACITY 3 0.0326
21 CILIARY BODY DISORDER 3 0.0303
22 PRODUCT CONTAINER SEAL ISSUE 49 0.0281
23 OPEN ANGLE GLAUCOMA 17 0.0277
24 OCULAR SURFACE DISEASE 7 0.0249
25 REACTION TO PRESERVATIVES 20 0.0246
26 IRIS HYPERPIGMENTATION 5 0.0240
27 TREATMENT FAILURE 1951 0.0235
28 INTRAOCULAR PRESSURE INCREASED 299 0.0234
29 INTRAOCULAR PRESSURE TEST ABNORMAL 16 0.0227
30 BURSITIS INFECTIVE 12 0.0221
31 TRICHIASIS 7 0.0220
32 HYPOTONY OF EYE 9 0.0214
33 EYE ALLERGY 32 0.0206
34 BLEPHARAL PIGMENTATION 10 0.0198
35 MILIA 7 0.0193
36 BLOOD IMMUNOGLOBULIN E INCREASED 44 0.0182
37 EYELID INJURY 3 0.0170
38 EYELASH CHANGES 3 0.0169
39 CHOROIDAL DETACHMENT 9 0.0162
40 LID SULCUS DEEPENED 6 0.0161
41 CHOROIDAL EFFUSION 12 0.0149
42 ELECTROLYTE DEPLETION 7 0.0142
43 PUNCTATE KERATITIS 13 0.0142
44 CORNEAL INFECTION 3 0.0138
45 DARK CIRCLES UNDER EYES 20 0.0136
46 GLAUCOMA 260 0.0135
47 CORNEA VERTICILLATA 4 0.0132
48 ANTERIOR CHAMBER DISORDER 3 0.0130
49 HAEMORRHAGIC CYST 5 0.0129
50 MACULAR DETACHMENT 3 0.0124
51 CORNEAL DEGENERATION 3 0.0124
52 PRODUCT DESIGN ISSUE 8 0.0112
53 CORNEAL EROSION 6 0.0111
54 TONGUE HAEMORRHAGE 13 0.0111
55 TRACHEO-OESOPHAGEAL FISTULA 7 0.0110
56 ILIAC ARTERY OCCLUSION 3 0.0109
57 CHEMICAL BURNS OF EYE 3 0.0108
58 OCULAR HYPERAEMIA 503 0.0106
59 EYELID THICKENING 3 0.0105
60 KERATIC PRECIPITATES 5 0.0105
61 FOREIGN BODY SENSATION IN EYES 67 0.0105
62 LENS DISORDER 3 0.0104
63 EYELID MARGIN CRUSTING 30 0.0104
64 PRODUCT CONTAINER ISSUE 85 0.0099
65 CORNEAL LESION 3 0.0097
66 EYE INFECTION VIRAL 3 0.0093
67 FLUID REPLACEMENT 3 0.0089
68 MACULAR FIBROSIS 6 0.0088
69 BLEPHARITIS 35 0.0087
70 EYE IRRITATION 499 0.0087
71 OPTIC NERVE INJURY 10 0.0086
72 LACRIMATION DECREASED 4 0.0084
73 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 3 0.0083
74 CORNEAL OPACITY 11 0.0081
75 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 7 0.0079
76 EYE COLOUR CHANGE 8 0.0079
77 EYE INFECTION FUNGAL 3 0.0078
78 EYELID EXFOLIATION 6 0.0076
79 INSTILLATION SITE ERYTHEMA 4 0.0076
80 EROSIVE DUODENITIS 6 0.0075
81 GINGIVAL DISCOLOURATION 4 0.0074
82 EYELID PAIN 15 0.0074
83 CYST RUPTURE 5 0.0074
84 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 13 0.0073
85 GASTROENTERITIS SALMONELLA 6 0.0072
86 OCULAR HYPERTENSION 14 0.0072
87 OCULAR DISCOMFORT 79 0.0070
88 GASTROINTESTINAL BACTERIAL INFECTION 8 0.0070
89 XEROPHTHALMIA 4 0.0068
90 EYELID IRRITATION 17 0.0068
91 ANAEMIA MEGALOBLASTIC 3 0.0067
92 JOINT NOISE 13 0.0066
93 RETINAL DISORDER 17 0.0065
94 EYELIDS PRURITUS 20 0.0064
95 SUPERFICIAL INJURY OF EYE 7 0.0064
96 ANAPHYLACTOID SHOCK 3 0.0064
97 CORNEAL DISORDER 14 0.0064
98 BRONCHIECTASIS 43 0.0064
99 METAPLASIA 3 0.0064
100 NEUTROPENIC INFECTION 6 0.0063
101 EYE PAIN 352 0.0062
102 EYELID DISORDER 14 0.0061
103 EAR INJURY 3 0.0061
104 HYPHAEMA 3 0.0057
105 ERYTHEMA OF EYELID 31 0.0057
106 GLASSY EYES 4 0.0056
107 ABNORMAL SENSATION IN EYE 24 0.0056
108 PRODUCT DELIVERY MECHANISM ISSUE 30 0.0056
109 BLOOD POTASSIUM ABNORMAL 14 0.0052
110 CORNEAL EPITHELIUM DEFECT 3 0.0052
111 CORNEAL TRANSPLANT 4 0.0051
112 HYPOAESTHESIA EYE 3 0.0051
113 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0050
114 EYE PRURITUS 165 0.0049
115 CYSTOID MACULAR OEDEMA 9 0.0048
116 CONJUNCTIVAL HYPERAEMIA 17 0.0048
117 EYE DISCHARGE 49 0.0047
118 IRITIS 14 0.0046
119 LIQUID PRODUCT PHYSICAL ISSUE 32 0.0044
120 ULCERATIVE KERATITIS 12 0.0044
121 PRODUCT PACKAGING ISSUE 41 0.0043
122 MACULAR OEDEMA 24 0.0043
123 OPTIC NEUROPATHY 9 0.0042
124 ANTERIOR CHAMBER CELL 3 0.0042
125 FOREIGN BODY IN EYE 4 0.0042
126 BLINDNESS UNILATERAL 58 0.0041
127 EYELID RASH 4 0.0041
128 FULL BLOOD COUNT ABNORMAL 43 0.0041
129 HYPERAEMIA 8 0.0041
130 CONJUNCTIVITIS ALLERGIC 6 0.0040
131 CORNEAL DEPOSITS 3 0.0040
132 CORNEAL OEDEMA 9 0.0040
133 EYE INJURY 12 0.0039
134 AORTIC DISORDER 3 0.0038
135 EXCESSIVE GRANULATION TISSUE 3 0.0037
136 INSTILLATION SITE REACTION 4 0.0037
137 BALANOPOSTHITIS 3 0.0036
138 VISUAL FIELD DEFECT 26 0.0036
139 ENDOCRINE OPHTHALMOPATHY 3 0.0035
140 INSTILLATION SITE IRRITATION 4 0.0034
141 METAMORPHOPSIA 6 0.0033
142 CANCER PAIN 8 0.0031
143 DACRYOSTENOSIS ACQUIRED 4 0.0031
144 EYE INFLAMMATION 29 0.0030
145 PHOTOPHOBIA 57 0.0030
146 DRY EYE 148 0.0030
147 ASTHENOPIA 16 0.0029
148 EYE DISORDER 94 0.0029
149 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
150 PLATELET DISORDER 7 0.0028
151 NORMOCYTIC ANAEMIA 4 0.0027
152 SWELLING OF EYELID 17 0.0027
153 EXCESSIVE EYE BLINKING 4 0.0027
154 APRAXIA 4 0.0027
155 RETINAL DETACHMENT 24 0.0026
156 BLINDNESS 106 0.0026
157 PRODUCT DEPOSIT 4 0.0026
158 IRIDOCYCLITIS 8 0.0025
159 LACRIMATION INCREASED 76 0.0025
160 ALLERGIC REACTION TO EXCIPIENT 5 0.0025
161 NEUTROPHIL COUNT ABNORMAL 7 0.0025
162 TENSION 15 0.0025
163 POLYP 16 0.0024
164 VEIN RUPTURE 4 0.0024
165 MACULAR DEGENERATION 28 0.0023
166 SPONDYLOLISTHESIS 4 0.0023
167 CORNEAL ABRASION 3 0.0022
168 EYELID OEDEMA 25 0.0021
169 ATYPICAL FEMUR FRACTURE 6 0.0021
170 HYPOACUSIS 91 0.0021
171 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
172 VISUAL ACUITY REDUCED 69 0.0021
173 PURULENCE 4 0.0021
174 PERSECUTORY DELUSION 5 0.0020
175 BLOOD CULTURE POSITIVE 6 0.0020
176 ERYSIPELAS 10 0.0020
177 AGE-RELATED MACULAR DEGENERATION 3 0.0020
178 KERATITIS 6 0.0020
179 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
180 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
181 PRODUCT USE COMPLAINT 30 0.0019
182 KERATOPATHY 3 0.0019
183 INCORRECT DOSE ADMINISTERED BY PRODUCT 3 0.0019
184 PRODUCT DISPENSING ISSUE 8 0.0019
185 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 63 0.0019
186 EYE SWELLING 68 0.0018
187 VISUAL IMPAIRMENT 226 0.0018
188 CATARACT 108 0.0018
189 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
190 NEPHROGENIC ANAEMIA 8 0.0017
191 VISION BLURRED 236 0.0017
192 EXPIRED PRODUCT ADMINISTERED 57 0.0017
193 PRODUCT AVAILABILITY ISSUE 39 0.0017
194 MACULOPATHY 6 0.0017
195 EYE INFECTION 19 0.0017
196 MEDICATION RESIDUE PRESENT 8 0.0017
197 ESSENTIAL HYPERTENSION 3 0.0016
198 EYE OEDEMA 4 0.0016
199 CHEST X-RAY ABNORMAL 5 0.0016
200 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
201 EYE MOVEMENT DISORDER 11 0.0016
202 URINE OUTPUT DECREASED 14 0.0016
203 HYPERPARATHYROIDISM SECONDARY 4 0.0016
204 LABYRINTHITIS 4 0.0016
205 ANGLE CLOSURE GLAUCOMA 4 0.0016
206 SENSATION OF FOREIGN BODY 13 0.0015
207 PROSTATOMEGALY 6 0.0015
208 VITREOUS FLOATERS 15 0.0015
209 POLYDIPSIA 6 0.0015
210 WALKING AID USER 10 0.0015
211 CHEST INJURY 3 0.0014
212 HYPERSENSITIVITY 269 0.0014
213 PRODUCT PHYSICAL CONSISTENCY ISSUE 8 0.0014
214 CAROTID ARTERY STENOSIS 5 0.0014
215 PRODUCT LEAKAGE 8 0.0014
216 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
217 BLOOD TESTOSTERONE INCREASED 3 0.0014
218 EXOPHTHALMOS 3 0.0014
219 EXPOSED BONE IN JAW 3 0.0014
220 ESCHERICHIA SEPSIS 4 0.0014
221 CARDIAC FAILURE ACUTE 9 0.0013
222 PRODUCT LABEL ISSUE 9 0.0013
223 TROPONIN INCREASED 10 0.0013
224 HAIR GROWTH ABNORMAL 9 0.0013
225 RHINORRHOEA 84 0.0013
226 OESOPHAGITIS 14 0.0013
227 EYE HAEMORRHAGE 17 0.0013
228 SEASONAL ALLERGY 18 0.0013
229 INFUSION SITE PRURITUS 4 0.0013
230 NEOPLASM 14 0.0012
231 INSTILLATION SITE PAIN 3 0.0012
232 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
233 APPLICATION SITE SWELLING 6 0.0012
234 SKIN LACERATION 13 0.0012
235 PRODUCT ADMINISTRATION ERROR 24 0.0012
236 EYELID PTOSIS 12 0.0012
237 ENDOPHTHALMITIS 7 0.0012
238 WOUND COMPLICATION 4 0.0012
239 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
240 LARGE INTESTINE POLYP 8 0.0012
241 THERAPY PARTIAL RESPONDER 18 0.0012
242 EXTRASYSTOLES 8 0.0011
243 RETINAL HAEMORRHAGE 8 0.0011
244 PRODUCT RESIDUE PRESENT 6 0.0011
245 URINARY TRACT DISORDER 5 0.0011
246 PHOTOPSIA 7 0.0011
247 NASAL CONGESTION 65 0.0011
248 BLINDNESS TRANSIENT 8 0.0011
249 PERIORBITAL SWELLING 6 0.0011
250 SPINAL COLUMN STENOSIS 5 0.0011
251 TRANSFUSION 11 0.0010
252 PARANASAL SINUS HYPERSECRETION 4 0.0010
253 RENAL FAILURE CHRONIC 8 0.0010
254 HAEMOLYSIS 8 0.0010
255 COMA SCALE ABNORMAL 3 0.0010
256 HAEMOTHORAX 3 0.0010
257 MUSCULOSKELETAL CHEST PAIN 16 0.0010
258 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
259 BODY HEIGHT DECREASED 11 0.0010
260 HYPOVOLAEMIA 6 0.0010
261 CONJUNCTIVITIS 19 0.0010
262 MULTIPLE ALLERGIES 8 0.0010
263 INFUSION SITE REACTION 3 0.0010
264 HEART RATE DECREASED 35 0.0010
265 CEREBROVASCULAR DISORDER 3 0.0010
266 PRODUCT SUPPLY ISSUE 7 0.0010
267 MASTICATION DISORDER 3 0.0010
268 PHLEBITIS 5 0.0010
269 IRON DEFICIENCY ANAEMIA 9 0.0010
270 PRODUCT COLOUR ISSUE 5 0.0010
271 PIGMENTATION DISORDER 6 0.0010
272 BASAL CELL CARCINOMA 15 0.0010
273 WHEEZING 57 0.0010
274 INFUSION SITE SWELLING 6 0.0010
275 PULMONARY MASS 14 0.0009
276 BREAST CANCER METASTATIC 10 0.0009
277 LOOSE TOOTH 3 0.0009
278 TEARFULNESS 4 0.0009
279 DIZZINESS POSTURAL 9 0.0009
280 PAROSMIA 7 0.0009
281 MYOPATHY 8 0.0009
282 FACET JOINT SYNDROME 3 0.0009
283 ACCIDENT 11 0.0009
284 NONSPECIFIC REACTION 5 0.0009
285 RESPIRATORY RATE INCREASED 8 0.0009
286 FACIAL PAIN 8 0.0009
287 LUMBAR VERTEBRAL FRACTURE 4 0.0009
288 EYE OPERATION 4 0.0009
289 FRUSTRATION TOLERANCE DECREASED 7 0.0009
290 HYPOPNOEA 3 0.0009
291 POLYURIA 7 0.0009
292 HANGOVER 3 0.0009
293 ESCHERICHIA INFECTION 7 0.0009
294 PAIN IN JAW 24 0.0008
295 DEMENTIA 23 0.0008
296 BLOOD PRESSURE SYSTOLIC INCREASED 16 0.0008
297 VITAMIN D DEFICIENCY 8 0.0008
298 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
299 FOOT DEFORMITY 9 0.0008
300 CEREBRAL DISORDER 6 0.0008
301 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
302 PRODUCT SUBSTITUTION ISSUE 46 0.0008
303 BLEPHAROSPASM 5 0.0008
304 FACE INJURY 3 0.0008
305 PATHOLOGICAL FRACTURE 4 0.0008
306 SLEEP APNOEA SYNDROME 15 0.0008
307 CLAVICLE FRACTURE 3 0.0008
308 VARICOSE VEIN 4 0.0008
309 EPIGASTRIC DISCOMFORT 3 0.0008
310 DEAFNESS 20 0.0008
311 SCIATICA 12 0.0008
312 WRIST FRACTURE 9 0.0008
313 STRESS FRACTURE 4 0.0007
314 UVEITIS 10 0.0007
315 PRODUCTIVE COUGH 35 0.0007
316 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
317 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
318 DEAFNESS UNILATERAL 4 0.0007
319 PROSTATIC DISORDER 4 0.0007
320 HYPERKERATOSIS 4 0.0007
321 ILEUS 9 0.0007
322 SKIN DISCOLOURATION 33 0.0007
323 HAND FRACTURE 5 0.0007
324 HEPATIC PAIN 3 0.0007
325 NEUTROPENIC SEPSIS 5 0.0007
326 PRODUCT QUALITY ISSUE 95 0.0007
327 SKIN HYPERPIGMENTATION 6 0.0007
328 SKIN ATROPHY 4 0.0007
329 FAECES DISCOLOURED 15 0.0007
330 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
331 MADAROSIS 8 0.0007
332 SKIN WARM 4 0.0007
333 TOOTH ABSCESS 7 0.0007
334 OSTEOARTHRITIS 29 0.0007
335 HAEMORRHAGIC ANAEMIA 3 0.0007
336 EAR DISCOMFORT 7 0.0007
337 BACK DISORDER 11 0.0007
338 SINUS HEADACHE 4 0.0007
339 CARDIAC PACEMAKER INSERTION 4 0.0007
340 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
341 ASTHMA 75 0.0007
342 CORONARY ARTERY DISEASE 20 0.0007
343 HYPOGLYCAEMIA 32 0.0007
344 HYPONATRAEMIA 37 0.0007
345 DRUG DISPENSING ERROR 10 0.0007
346 BOWEL MOVEMENT IRREGULARITY 5 0.0007
347 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
348 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
349 THYROID DISORDER 10 0.0006
350 GASTRITIS EROSIVE 3 0.0006
351 PELVIC FRACTURE 5 0.0006
352 BRADYCARDIA 34 0.0006
353 PRE-EXISTING CONDITION IMPROVED 4 0.0006
354 EAR INFECTION 17 0.0006
355 BALANCE DISORDER 55 0.0006
356 DIALYSIS 9 0.0006
357 TRICUSPID VALVE INCOMPETENCE 5 0.0006
358 FREQUENT BOWEL MOVEMENTS 17 0.0006
359 LIMB INJURY 17 0.0006
360 FAECAL INCONTINENCE 3 0.0006
361 SNEEZING 14 0.0006
362 HUMERUS FRACTURE 3 0.0006
363 MYASTHENIA GRAVIS 5 0.0006
364 EXTRA DOSE ADMINISTERED 25 0.0006
365 DECUBITUS ULCER 5 0.0006
366 GASTRITIS 16 0.0006
367 ORAL CANDIDIASIS 8 0.0006
368 DYSGRAPHIA 4 0.0006
369 PRODUCT FORMULATION ISSUE 4 0.0006
370 SINUS DISORDER 12 0.0006
371 ANEURYSM 3 0.0006
372 UPPER LIMB FRACTURE 12 0.0006
373 EPISTAXIS 45 0.0006
374 HYPERKALAEMIA 21 0.0006
375 TERMINAL STATE 4 0.0006
376 KLEBSIELLA INFECTION 3 0.0006
377 FACE OEDEMA 10 0.0006
378 DYSPHORIA 3 0.0006
379 CORONARY ARTERIAL STENT INSERTION 3 0.0006
380 PRODUCT TASTE ABNORMAL 8 0.0006
381 DRY THROAT 6 0.0006
382 HYPERLIPIDAEMIA 7 0.0006
383 FEMORAL NECK FRACTURE 3 0.0006
384 PRODUCT DOSE OMISSION ISSUE 172 0.0006
385 BURNING SENSATION 41 0.0006
386 INCREASED UPPER AIRWAY SECRETION 3 0.0006
387 SKIN ULCER 15 0.0006
388 FALL 193 0.0006
389 DELUSION 9 0.0006
390 BLOOD MAGNESIUM DECREASED 5 0.0006
391 DIABETES MELLITUS 44 0.0006
392 LARGE INTESTINE PERFORATION 4 0.0006
393 HEART RATE IRREGULAR 13 0.0006
394 FORMICATION 4 0.0006
395 FEELING COLD 16 0.0006
396 DEFAECATION URGENCY 4 0.0006
397 BLOOD PRESSURE INCREASED 87 0.0006
398 SCRATCH 6 0.0006
399 INCONTINENCE 6 0.0006
400 HEAD DISCOMFORT 10 0.0006
401 DEHYDRATION 75 0.0006
402 ACUTE KIDNEY INJURY 86 0.0006
403 SUBDURAL HAEMATOMA 8 0.0006
404 MYOSITIS 5 0.0006
405 PRURITUS GENERALISED 12 0.0006
406 HIP SURGERY 3 0.0006
407 DYSGEUSIA 41 0.0006
408 BACK INJURY 6 0.0006
409 PRODUCT DOSE OMISSION 36 0.0006
410 COUGH 154 0.0005
411 GASTROENTERITIS 8 0.0005
412 ORAL DISORDER 4 0.0005
413 MYDRIASIS 7 0.0005
414 ATRIAL FIBRILLATION 53 0.0005
415 HALLUCINATION 41 0.0005
416 DYSURIA 20 0.0005
417 NERVE COMPRESSION 5 0.0005
418 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
419 DISCOMFORT 33 0.0005
420 DIPLOPIA 14 0.0005
421 CONFUSIONAL STATE 87 0.0005
422 HEAD INJURY 17 0.0005
423 WOUND 15 0.0005
424 THROAT IRRITATION 24 0.0005
425 RIB FRACTURE 11 0.0005
426 MUSCULOSKELETAL PAIN 28 0.0005
427 TOOTH INFECTION 7 0.0005
428 BLOOD SODIUM DECREASED 10 0.0005
429 CHOLECYSTITIS ACUTE 3 0.0005
430 HAEMOGLOBIN DECREASED 54 0.0005
431 HYPERTONIA 3 0.0005
432 EXERCISE TOLERANCE DECREASED 3 0.0005
433 ARTHRITIS 41 0.0005
434 HALLUCINATION, VISUAL 11 0.0005
435 FEAR 14 0.0005
436 ATRIOVENTRICULAR BLOCK 4 0.0005
437 ANKLE FRACTURE 8 0.0005
438 CONCUSSION 4 0.0005
439 JOINT INJURY 11 0.0005
440 DYSPHONIA 30 0.0005
441 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
442 BLOOD PRESSURE DECREASED 34 0.0005
443 DECREASED INTEREST 3 0.0005
444 DRUG INTOLERANCE 49 0.0005
445 ARRHYTHMIA 24 0.0005
446 HOSPICE CARE 5 0.0005
447 BACTERAEMIA 6 0.0005
448 NASAL DISCOMFORT 4 0.0005
449 ATRIAL FLUTTER 4 0.0005
450 TINNITUS 23 0.0005
451 FULL BLOOD COUNT DECREASED 10 0.0005
452 HYPERGLYCAEMIA 18 0.0005
453 END STAGE RENAL DISEASE 9 0.0005
454 INGUINAL HERNIA 3 0.0005
455 BLOOD POTASSIUM INCREASED 8 0.0005
456 NEUTROPHIL COUNT DECREASED 20 0.0005
457 MENISCUS INJURY 3 0.0005
458 PERIPHERAL SWELLING 75 0.0005
459 HAIR DISORDER 4 0.0005
460 PHOTOSENSITIVITY REACTION 8 0.0005
461 INFUSION SITE EXTRAVASATION 3 0.0005
462 POLLAKIURIA 20 0.0005
463 DYSPNOEA EXERTIONAL 18 0.0005
464 INFUSION SITE ERYTHEMA 4 0.0005
465 DIZZINESS 236 0.0005
466 NO ADVERSE EVENT 85 0.0005
467 URINARY TRACT INFECTION 80 0.0005
468 MENTAL STATUS CHANGES 13 0.0005
469 VITAMIN D DECREASED 4 0.0005
470 CONSTIPATION 102 0.0005
471 ROTATOR CUFF SYNDROME 6 0.0005
472 HIP FRACTURE 15 0.0005
473 HIATUS HERNIA 6 0.0005
474 APPLICATION SITE VESICLES 3 0.0005
475 NASOPHARYNGITIS 85 0.0005
476 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
477 SPEECH DISORDER 24 0.0005
478 HYPOGAMMAGLOBULINAEMIA 3 0.0005
479 INTENTIONAL PRODUCT USE ISSUE 40 0.0005
480 WOUND INFECTION 5 0.0005
481 ACCIDENTAL EXPOSURE TO PRODUCT 47 0.0005
482 GROIN PAIN 4 0.0005
483 SPINAL OSTEOARTHRITIS 4 0.0005
484 IMMUNE SYSTEM DISORDER 6 0.0005
485 PULMONARY CONGESTION 6 0.0005
486 LUNG INFILTRATION 4 0.0005
487 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
488 WRONG DRUG ADMINISTERED 4 0.0004
489 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
490 ORAL PAIN 10 0.0004
491 HAEMOLYTIC ANAEMIA 4 0.0004
492 SWELLING FACE 29 0.0004
493 COLITIS ISCHAEMIC 3 0.0004
494 SINUS CONGESTION 6 0.0004
495 FEEDING DISORDER 9 0.0004
496 OROPHARYNGEAL DISCOMFORT 4 0.0004
497 MITRAL VALVE INCOMPETENCE 5 0.0004
498 PNEUMOTHORAX 7 0.0004
499 FLATULENCE 25 0.0004
500 URINARY INCONTINENCE 13 0.0004
501 GASTRIC HAEMORRHAGE 5 0.0004
502 HAEMATEMESIS 11 0.0004
503 PRODUCT DISTRIBUTION ISSUE 4 0.0004
504 PERSONALITY CHANGE 4 0.0004
505 RASH MACULAR 15 0.0004
506 MANIA 7 0.0004
507 LACERATION 4 0.0004
508 LYMPHOPENIA 6 0.0004
509 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
510 CARDIAC FAILURE 34 0.0004
511 COVID-19 PNEUMONIA 5 0.0004
512 FRACTURE 8 0.0004
513 MUSCULOSKELETAL STIFFNESS 37 0.0004
514 DIVERTICULUM 3 0.0004
515 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
516 LIP SWELLING 14 0.0004
517 COAGULOPATHY 7 0.0004
518 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
519 BLOOD PRESSURE FLUCTUATION 10 0.0004
520 SWOLLEN TONGUE 13 0.0004
521 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
522 HYPERTENSION 88 0.0004
523 ANOSMIA 6 0.0004
524 NEPHROLITHIASIS 19 0.0004
525 DRUG INEFFECTIVE 545 0.0004
526 LOCALISED INFECTION 10 0.0004
527 MENTAL IMPAIRMENT 10 0.0004
528 FAECES SOFT 3 0.0004
529 MALAISE 180 0.0004
530 AUTOIMMUNE DISORDER 4 0.0004
531 PARKINSONISM 4 0.0004
532 HAEMATURIA 14 0.0004
533 DYSPEPSIA 40 0.0004
534 DISABILITY 8 0.0004
535 LIGAMENT SPRAIN 4 0.0004
536 DELIRIUM 14 0.0004
537 BLADDER DISORDER 4 0.0004
538 NERVOUSNESS 21 0.0004
539 HAIR COLOUR CHANGES 5 0.0004
540 HYPOAESTHESIA ORAL 6 0.0004
541 EMPHYSEMA 4 0.0004
542 ECONOMIC PROBLEM 6 0.0004
543 CARDIAC DISORDER 37 0.0004
544 DRY MOUTH 32 0.0004
545 AORTIC ANEURYSM 3 0.0004
546 MEMORY IMPAIRMENT 54 0.0004
547 SUBARACHNOID HAEMORRHAGE 4 0.0004
548 THIRST 7 0.0004
549 LOSS OF CONSCIOUSNESS 50 0.0004
550 OSTEOPOROSIS 16 0.0004
551 ASTHENIA 146 0.0004
552 DECREASED APPETITE 90 0.0004
553 TOOTHACHE 7 0.0004
554 HAEMATOMA 10 0.0004
555 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
556 RESTLESS LEGS SYNDROME 7 0.0004
557 TENDERNESS 4 0.0004
558 RHABDOMYOLYSIS 16 0.0004
559 UNDERDOSE 28 0.0004
560 PAIN IN EXTREMITY 113 0.0004
561 PLATELET COUNT INCREASED 5 0.0004
562 BACK PAIN 89 0.0004
563 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
564 PRODUCT ODOUR ABNORMAL 4 0.0004
565 INCORRECT PRODUCT STORAGE 5 0.0004
566 GASTRIC DISORDER 13 0.0004
567 FURUNCLE 3 0.0004
568 THERAPY NON-RESPONDER 17 0.0004
569 BLOOD ALBUMIN DECREASED 3 0.0004
570 HEADACHE 237 0.0004
571 RENAL FAILURE ACUTE 16 0.0004
572 DYSSTASIA 11 0.0004
573 MULTIPLE SCLEROSIS 18 0.0004
574 MOVEMENT DISORDER 12 0.0004
575 FLUID RETENTION 19 0.0004
576 JOINT RANGE OF MOTION DECREASED 5 0.0004
577 HEPATIC CIRRHOSIS 7 0.0004
578 SKIN CANCER 8 0.0004
579 SKIN IRRITATION 17 0.0004
580 GAIT DISTURBANCE 71 0.0004
581 DECREASED ACTIVITY 4 0.0004
582 FOOT FRACTURE 7 0.0004
583 BLOOD URINE PRESENT 7 0.0004
584 GASTROINTESTINAL DISORDER 33 0.0004
585 NEUROPATHY PERIPHERAL 35 0.0004
586 BIPOLAR DISORDER 4 0.0004
587 PALLOR 10 0.0004
588 ANAEMIA 70 0.0004
589 BLOOD POTASSIUM DECREASED 11 0.0004
590 HERPES ZOSTER 21 0.0004
591 DYSPNOEA 206 0.0004
592 ACUTE RESPIRATORY FAILURE 7 0.0004
593 HEART RATE INCREASED 36 0.0004
594 ACUTE CORONARY SYNDROME 3 0.0004
595 AGEUSIA 9 0.0004
596 NERVE INJURY 4 0.0004
597 NEOPLASM MALIGNANT 24 0.0004
598 GAIT INABILITY 12 0.0004
599 HUNGER 5 0.0004
600 BONE PAIN 21 0.0004
601 COORDINATION ABNORMAL 5 0.0004
602 DRUG ADMINISTRATION ERROR 11 0.0004
603 BLOOD UREA INCREASED 6 0.0004
604 APHONIA 5 0.0004
605 PULMONARY OEDEMA 16 0.0004
606 HAEMODIALYSIS 3 0.0004
607 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
608 LIMB DISCOMFORT 11 0.0004
609 INCORRECT DOSE ADMINISTERED 81 0.0004
610 CHROMATURIA 8 0.0004
611 HYPOPHAGIA 9 0.0004
612 CHEST DISCOMFORT 36 0.0004
613 DERMATITIS CONTACT 4 0.0004
614 MICTURITION URGENCY 4 0.0003
615 SYNCOPE 35 0.0003
616 PNEUMONIA 113 0.0003
617 JOINT SWELLING 42 0.0003
618 DYSPHAGIA 33 0.0003
619 SOMNOLENCE 70 0.0003
620 CARDIAC MURMUR 3 0.0003
621 METASTASES TO LUNG 4 0.0003
622 ERYTHEMA 71 0.0003
623 PSORIATIC ARTHROPATHY 14 0.0003
624 ORTHOSTATIC HYPOTENSION 6 0.0003
625 HYPOKINESIA 5 0.0003
626 ELECTROLYTE IMBALANCE 4 0.0003
627 FATIGUE 268 0.0003
628 POST PROCEDURAL HAEMORRHAGE 4 0.0003
629 CONTUSION 33 0.0003
630 INSOMNIA 91 0.0003
631 WEIGHT DECREASED 95 0.0003
632 BRONCHITIS 25 0.0003
633 COLON CANCER 5 0.0003
634 ARTHRALGIA 139 0.0003
635 PRODUCT STORAGE ERROR 29 0.0003
636 OSTEOPENIA 5 0.0003
637 EATING DISORDER 7 0.0003
638 INSURANCE ISSUE 5 0.0003
639 BRAIN NEOPLASM 3 0.0003
640 INCREASED TENDENCY TO BRUISE 3 0.0003
641 MUSCLE SPASTICITY 4 0.0003
642 FEELING ABNORMAL 78 0.0003
643 SMALL INTESTINAL OBSTRUCTION 4 0.0003
644 SPINAL OPERATION 4 0.0003
645 CHEST PAIN 60 0.0003
646 INFLUENZA 36 0.0003
647 PRODUCT DISPENSING ERROR 7 0.0003
648 MIDDLE INSOMNIA 6 0.0003
649 COGNITIVE DISORDER 15 0.0003
650 DIARRHOEA HAEMORRHAGIC 3 0.0003
651 PNEUMONIA ASPIRATION 8 0.0003
652 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
653 ARTERIOSCLEROSIS 3 0.0003
654 MELAENA 7 0.0003
655 DERMATITIS ALLERGIC 4 0.0003
656 COLITIS 12 0.0003
657 MUSCLE SPASMS 58 0.0003
658 MUSCULOSKELETAL DISORDER 6 0.0003
659 DRUG INTERACTION 50 0.0003
660 TOOTH DISORDER 7 0.0003
661 HYPERSOMNIA 9 0.0003
662 SENSORY DISTURBANCE 5 0.0003
663 CARDIAC FAILURE CONGESTIVE 25 0.0003
664 ATELECTASIS 3 0.0003
665 INFUSION SITE PAIN 4 0.0003
666 NIGHT SWEATS 10 0.0003
667 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
668 CHOKING 6 0.0003
669 CEREBROVASCULAR ACCIDENT 52 0.0003
670 HEPATOMEGALY 3 0.0003
671 HOT FLUSH 23 0.0003
672 BODY TEMPERATURE DECREASED 3 0.0003
673 IMPAIRED HEALING 10 0.0003
674 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
675 BEDRIDDEN 4 0.0003
676 NECK PAIN 17 0.0003
677 UNEVALUABLE EVENT 23 0.0003
678 DEPRESSED MOOD 16 0.0003
679 HAEMATOCRIT DECREASED 6 0.0003
680 BLOOD PRESSURE ABNORMAL 6 0.0003
681 TREMOR 50 0.0003
682 ILLNESS 31 0.0003
683 RESPIRATORY DISORDER 9 0.0003
684 SKIN DISORDER 10 0.0003
685 SPINAL FRACTURE 6 0.0003
686 CYTOKINE RELEASE SYNDROME 6 0.0003
687 HYPOTENSION 60 0.0003
688 HAIR TEXTURE ABNORMAL 4 0.0003
689 PALPITATIONS 35 0.0003
690 PRODUCT USE ISSUE 56 0.0003
691 ABDOMINAL DISTENSION 31 0.0003
692 THERAPEUTIC RESPONSE DECREASED 18 0.0003
693 SEPSIS 33 0.0003
694 THROAT TIGHTNESS 8 0.0003
695 TASTE DISORDER 6 0.0003
696 LETHARGY 17 0.0003
697 OEDEMA PERIPHERAL 36 0.0003
698 RASH PRURITIC 16 0.0003
699 HEMIPARESIS 5 0.0003
700 OEDEMA 16 0.0003
701 MYALGIA 50 0.0003
702 IMPAIRED GASTRIC EMPTYING 4 0.0003
703 MUSCULOSKELETAL DISCOMFORT 5 0.0003
704 RESPIRATORY DISTRESS 8 0.0003
705 HYPERBILIRUBINAEMIA 3 0.0003
706 DIVERTICULITIS 8 0.0003
707 DIARRHOEA 186 0.0003
708 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
709 ABDOMINAL DISCOMFORT 48 0.0003
710 RENAL IMPAIRMENT 24 0.0003
711 BLOOD TEST ABNORMAL 4 0.0003
712 COLD SWEAT 5 0.0003
713 CYSTITIS 9 0.0003
714 PLASMA CELL MYELOMA 11 0.0003
715 CHILLS 33 0.0003
716 PLATELET COUNT DECREASED 30 0.0003
717 PRURITUS 108 0.0003
718 PARALYSIS 4 0.0003
719 CELLULITIS 14 0.0003
720 DEPRESSION 63 0.0003
721 WEIGHT INCREASED 62 0.0003
722 OSTEOMYELITIS 5 0.0003
723 PRODUCT PRESCRIBING ISSUE 6 0.0003
724 FLUID OVERLOAD 4 0.0003
725 BONE DISORDER 5 0.0003
726 ASPIRATION 3 0.0003
727 BLOOD GLUCOSE FLUCTUATION 3 0.0003
728 SINUSITIS 28 0.0003
729 CONDITION AGGRAVATED 83 0.0003
730 FEBRILE NEUTROPENIA 18 0.0003
731 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
732 RASH GENERALISED 7 0.0003
733 ARTHROPATHY 15 0.0003
734 URINARY RETENTION 9 0.0003
735 RENAL INJURY 8 0.0003
736 RESPIRATORY TRACT INFECTION 7 0.0003
737 BACTERIAL INFECTION 5 0.0003
738 TYPE 2 DIABETES MELLITUS 9 0.0003
739 BLISTER 15 0.0003
740 OXYGEN SATURATION DECREASED 15 0.0003
741 BONE LOSS 4 0.0003
742 APHASIA 8 0.0003
743 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
744 MUSCULAR WEAKNESS 30 0.0003
745 CHRONIC KIDNEY DISEASE 20 0.0003
746 CHOLECYSTECTOMY 3 0.0003
747 INTERNAL HAEMORRHAGE 3 0.0003
748 VERTIGO 16 0.0003
749 COVID-19 46 0.0003
750 SHOCK 6 0.0003
751 SKIN EXFOLIATION 22 0.0003
752 PULMONARY FIBROSIS 5 0.0003
753 LOWER LIMB FRACTURE 5 0.0003
754 NIGHTMARE 9 0.0003
755 DEVICE RELATED INFECTION 4 0.0003
756 TENDONITIS 4 0.0003
757 FEMUR FRACTURE 8 0.0003
758 EAR PAIN 5 0.0003
759 ACUTE MYELOID LEUKAEMIA 4 0.0003
760 RECTAL HAEMORRHAGE 11 0.0003
761 HYPOAESTHESIA 38 0.0003
762 THERAPY CESSATION 13 0.0003
763 ATAXIA 3 0.0003
764 OBESITY 4 0.0003
765 PRESCRIBED UNDERDOSE 5 0.0003
766 PANCYTOPENIA 14 0.0003
767 PYREXIA 86 0.0002
768 RENAL FAILURE 33 0.0002
769 INJECTION SITE SWELLING 19 0.0002
770 ADRENAL INSUFFICIENCY 3 0.0002
771 MUSCLE TIGHTNESS 4 0.0002
772 PRESYNCOPE 6 0.0002
773 BONE MARROW FAILURE 5 0.0002
774 INTENTIONAL DOSE OMISSION 7 0.0002
775 BLOOD CREATININE INCREASED 16 0.0002
776 CYTOPENIA 3 0.0002
777 FEELING HOT 15 0.0002
778 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
779 DEATH 208 0.0002
780 DRUG EFFECT DECREASED 13 0.0002
781 PULMONARY HYPERTENSION 5 0.0002
782 ROAD TRAFFIC ACCIDENT 10 0.0002
783 PERICARDITIS 4 0.0002
784 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
785 OROPHARYNGEAL PAIN 22 0.0002
786 KNEE ARTHROPLASTY 5 0.0002
787 ACUTE MYOCARDIAL INFARCTION 7 0.0002
788 MOUTH ULCERATION 5 0.0002
789 TACHYCARDIA 21 0.0002
790 RENAL DISORDER 11 0.0002
791 PAIN 145 0.0002
792 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
793 PARAESTHESIA 37 0.0002
794 SWELLING 22 0.0002
795 NAUSEA 186 0.0002
796 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
797 IRRITABLE BOWEL SYNDROME 5 0.0002
798 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
799 INFLAMMATION 12 0.0002
800 PARANOIA 4 0.0002
801 ANXIETY 66 0.0002
802 HAEMORRHAGE 24 0.0002
803 LOCAL SWELLING 4 0.0002
804 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
805 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
806 INJECTION SITE HAEMORRHAGE 18 0.0002
807 GALLBLADDER DISORDER 4 0.0002
808 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
809 CEREBRAL HAEMORRHAGE 8 0.0002
810 JAUNDICE 6 0.0002
811 GOUT 4 0.0002
812 PSORIASIS 29 0.0002
813 DYSKINESIA 9 0.0002
814 MOOD ALTERED 6 0.0002
815 DISEASE PROGRESSION 26 0.0002
816 MOOD SWINGS 7 0.0002
817 ACCIDENTAL OVERDOSE 8 0.0002
818 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
819 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
820 ABNORMAL DREAMS 6 0.0002
821 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
822 FLUSHING 22 0.0002
823 PERICARDIAL EFFUSION 5 0.0002
824 HYPOMAGNESAEMIA 3 0.0002
825 AMNESIA 14 0.0002
826 BLOOD CHOLESTEROL INCREASED 10 0.0002
827 ILL-DEFINED DISORDER 13 0.0002
828 PLEURAL EFFUSION 13 0.0002
829 OFF LABEL USE 187 0.0002
830 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
831 MYOCARDIAL INFARCTION 37 0.0002
832 PRODUCT PRESCRIBING ERROR 5 0.0002
833 ANGINA PECTORIS 6 0.0002
834 CARDIOGENIC SHOCK 3 0.0002
835 ABDOMINAL PAIN UPPER 43 0.0002
836 RASH 91 0.0002
837 DIABETIC KETOACIDOSIS 5 0.0002
838 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
839 HYPERTHYROIDISM 3 0.0002
840 INFLUENZA LIKE ILLNESS 17 0.0002
841 RESPIRATORY FAILURE 15 0.0002
842 APATHY 3 0.0002
843 SKIN FISSURES 4 0.0002
844 LABORATORY TEST ABNORMAL 6 0.0002
845 CARDIOMYOPATHY 3 0.0002
846 DRY SKIN 27 0.0002
847 ABDOMINAL PAIN 47 0.0002
848 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
849 ADVERSE DRUG REACTION 18 0.0002
850 IRRITABILITY 12 0.0002
851 PRODUCT PHYSICAL ISSUE 4 0.0002
852 INJURY ASSOCIATED WITH DEVICE 4 0.0002
853 VOMITING 92 0.0002
854 MOBILITY DECREASED 14 0.0002
855 LYMPHOMA 3 0.0002
856 ALOPECIA 38 0.0002
857 PANIC ATTACK 7 0.0002
858 NEUTROPENIA 26 0.0002
859 DERMATITIS 4 0.0002
860 JOINT STIFFNESS 5 0.0002
861 MIGRAINE 18 0.0002
862 INJECTION SITE BRUISING 15 0.0002
863 BLOOD GLUCOSE DECREASED 9 0.0002
864 INFECTION 27 0.0002
865 DYSARTHRIA 7 0.0002
866 INTERSTITIAL LUNG DISEASE 9 0.0002
867 POOR QUALITY SLEEP 4 0.0002
868 LACTIC ACIDOSIS 6 0.0002
869 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
870 CHOLELITHIASIS 6 0.0002
871 METASTASES TO BONE 3 0.0002
872 DRUG LEVEL INCREASED 3 0.0002
873 HAEMATOCHEZIA 10 0.0002
874 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
875 LIVER DISORDER 8 0.0002
876 LEUKOPENIA 9 0.0002
877 MEDICATION ERROR 10 0.0002
878 URTICARIA 30 0.0002
879 THROMBOCYTOPENIA 20 0.0002
880 AGITATION 13 0.0002
881 DISORIENTATION 7 0.0002
882 CIRCULATORY COLLAPSE 3 0.0002
883 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
884 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
885 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
886 RED BLOOD CELL COUNT DECREASED 5 0.0002
887 ECZEMA 9 0.0002
888 LIVER FUNCTION TEST ABNORMAL 5 0.0002
889 LUNG NEOPLASM MALIGNANT 7 0.0002
890 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
891 DEEP VEIN THROMBOSIS 11 0.0002
892 ISCHAEMIC STROKE 3 0.0002
893 THERAPY INTERRUPTED 12 0.0002
894 RASH ERYTHEMATOUS 8 0.0002
895 DRUG EFFECT INCOMPLETE 6 0.0002
896 FIBROMYALGIA 4 0.0002
897 SUICIDAL IDEATION 15 0.0002
898 ENCEPHALOPATHY 4 0.0002
899 THROMBOSIS 13 0.0002
900 HEPATIC ENZYME INCREASED 11 0.0002
901 INTESTINAL OBSTRUCTION 6 0.0002
902 GASTRIC ULCER 3 0.0002
903 DRUG DOSE OMISSION 26 0.0002
904 HYPOTHYROIDISM 5 0.0002
905 METABOLIC ACIDOSIS 5 0.0002
906 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
907 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
908 ERUCTATION 3 0.0002
909 EXPOSURE VIA SKIN CONTACT 4 0.0002
910 SURGERY 9 0.0002
911 KIDNEY INFECTION 3 0.0002
912 APPLICATION SITE ERYTHEMA 4 0.0002
913 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
914 VIRAL INFECTION 5 0.0002
915 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
916 INTENTIONAL PRODUCT MISUSE 13 0.0001
917 STOMATITIS 9 0.0001
918 HYPERHIDROSIS 19 0.0001
919 PULMONARY EMBOLISM 14 0.0001
920 TREATMENT NONCOMPLIANCE 8 0.0001
921 INJECTION SITE WARMTH 3 0.0001
922 SKIN LESION 4 0.0001
923 CARDIAC ARREST 12 0.0001
924 ACNE 11 0.0001
925 HAEMOPTYSIS 4 0.0001
926 LUNG DISORDER 7 0.0001
927 HYPOXIA 5 0.0001
928 SLEEP DISORDER 10 0.0001
929 PRODUCT USE IN UNAPPROVED INDICATION 35 0.0001
930 RHEUMATOID ARTHRITIS 16 0.0001
931 PANCREATIC CARCINOMA 4 0.0001
932 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
933 MENTAL DISORDER 6 0.0001
934 CRYING 5 0.0001
935 HOSPITALISATION 21 0.0001
936 RESTLESSNESS 5 0.0001
937 ANGIOEDEMA 6 0.0001
938 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
939 DISTURBANCE IN ATTENTION 7 0.0001
940 INJURY 9 0.0001
941 BLOOD GLUCOSE INCREASED 24 0.0001
942 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
943 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
944 COMA 6 0.0001
945 RENAL CANCER 6 0.0001
946 ABASIA 3 0.0001
947 SEIZURE 14 0.0001
948 DEVICE DIFFICULT TO USE 8 0.0001
949 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
950 FUNGAL INFECTION 4 0.0001
951 CARDIO-RESPIRATORY ARREST 5 0.0001
952 ABDOMINAL PAIN LOWER 3 0.0001
953 CARDIOVASCULAR DISORDER 3 0.0001
954 VAGINAL HAEMORRHAGE 5 0.0001
955 NEOPLASM PROGRESSION 4 0.0001
956 SEPTIC SHOCK 5 0.0001
957 MUCOSAL INFLAMMATION 3 0.0001
958 ANHEDONIA 3 0.0001
959 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
960 SKIN BURNING SENSATION 8 0.0001
961 BLOOD BILIRUBIN INCREASED 3 0.0001
962 INJECTION SITE PAIN 34 0.0001
963 HYPOKALAEMIA 5 0.0001
964 HEPATIC FUNCTION ABNORMAL 4 0.0001
965 DEVICE MALFUNCTION 7 0.0001
966 ADVERSE EVENT 9 0.0001
967 GYNAECOMASTIA 3 0.0001
968 WITHDRAWAL SYNDROME 4 0.0001
969 PANCREATITIS 5 0.0001
970 DEVICE DISLOCATION 4 0.0001
971 INFUSION RELATED REACTION 6 0.0001
972 ANAPHYLACTIC REACTION 5 0.0001
973 INJECTION SITE REACTION 6 0.0001
974 LYMPHADENOPATHY 3 0.0001
975 DISEASE RECURRENCE 4 0.0001
976 TOXICITY TO VARIOUS AGENTS 14 0.0001
977 C-REACTIVE PROTEIN INCREASED 3 0.0001
978 OVERDOSE 17 0.0001
979 ABNORMAL BEHAVIOUR 3 0.0001
980 EMOTIONAL DISTRESS 9 0.0001
981 INJECTION SITE ERYTHEMA 9 0.0001
982 BLADDER CANCER 4 0.0001
983 DEVICE ISSUE 6 0.0001
984 PROSTATE CANCER 5 0.0001
985 AGGRESSION 3 0.0001
986 INJECTION SITE PRURITUS 4 0.0001
987 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
988 DERMATITIS ATOPIC 3 0.0001
989 CONVULSION 3 0.0001
990 BREAST CANCER 4 0.0000
991 DRUG DEPENDENCE 5 0.0000